drugset / Trial / NCT06168461

Daily Aspirin Treatment After Preeclampsia

NCT06168461

Phase 0 Recruiting 40 enrolled Anna Stanhewicz, PhD
RandomizedParallel-groupQuadruple-blindBasic science

Summary

Women who develop preeclampsia during pregnancy are four times more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs may be related to lasting blood vessel damage after the pregnancy but there are currently no specific treatment strategies to prevent this disease progression. This study addresses this public health issue by examining whether starting low dose aspirin therapy after pregnancy is an effective treatment for lasting blood vessel damage in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.

Timeline

Start
2023-11-01
Primary completion
2026-06
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 162 mg

Indications